NNVC
NanoViricides Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
nanoviricides, inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. its products pipeline includes herpecide dermal topical and eye drops for the treatment of shingles, phn, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and herpecide intraocular injection for viral acute retinal necrosis. the company also develops flucide broad-spectrum anti-influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; nanoviricide eye drops for viral diseases of the external eye; denguecide for treatment of all types of dengue viruses; and hivcide that is an escape-resistant anti-hiv nanoviricide. in addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and herpecide program expansion drug projects for different herpes viruses for different indications. nanovir
Market Cap: 13.7 Million
Primary Exchange: NYSE MKT LLC
Website: http://www.nanoviricides.com/
Shares Outstanding: 11.8 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.3953749141491209
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Ethical Flags
Longest drawdown: 1557 trading days
From: 2014-06-23 To: 2020-01-22
Lowest Point:
NanoViricides, Inc. Appoints Dr. Mark Day to its Board of Directors
via: PR Newswire at 2019-06-10 03:00:00:000
SHELTON, Conn. , June 10, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, reports that Dr. Mark Day has been duly appointed as an Independent Director to its Board of Directors, effecti… read more...
NanoViricides, Inc. Appoints Dr. Mark Day to its Board of Directors
via: PR Newswire at 2019-06-10 03:00:00:000
SHELTON, Conn. , June 10, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, reports that Dr. Mark Day has been duly appointed as an Independent Director to its Board of Directors, effecti… read more...
NanoViricides, Inc. Appoints Dr. Mark Day to its Board of Directors
via: PR Newswire at 2019-06-10 03:00:00:000
SHELTON, Conn. , June 10, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, reports that Dr. Mark Day has been duly appointed as an Independent Director to its Board of Directors, effecti… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|